HFNJ Welcomes Dr. David Gutstein to the Board of TrusteesJune 14, 2022
The Healthcare Foundation of New Jersey is excited to announce that Dr. David E. Gutstein will join the Board of Trustees, starting in July 2022. As a physician and leading clinical researcher, Dr. Gutstein’s perspective will be invaluable in guiding the Foundation as it seeks to wisely invest in promising new approaches to improve the quality of and access to healthcare in our region.
Dr. Gutstein currently works as Vice President, Strategic Program Direction, Hematology Translational & Clinical Sciences at Regeneron Pharmaceuticals, where he is responsible for heading gene editing and other therapeutic programs addressing serious and debilitating diseases. He’s also an Adjunct Professor of Medicine at New York University Medical Center.
Dr. Gutstein trained in internal medicine at Harvard’s Beth Israel Hospital and in cardiology at Mount Sinai in New York. For his research, he received support from the National Institutes of Health and the American Heart Association (AHA), and was honored with the Katz Basic Science Prize of the AHA for his work on molecular and cellular mechanisms of arrhythmias.
In his charitable activities, he is active in the local Greater MetroWest Jewish community as a former member of the Board of the Golda Och Academy in West Orange, NJ, and an incoming Trustee of Congregation B’nai Israel in Millburn, NJ.
Dr. Gutstein is married to Dr. Alison Grann, the Chair of Radiation Oncology at the Cooperman Barnabas Medical Center in Livingston, NJ, and they have three children.